The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Clinical trial NCT05756322 · RECRUITING
Trial details
- NCT number
- NCT05756322
- Sponsor
- Lin BioScience, Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2026-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.